- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14:06 | Guggenheim raises Assembly Biosciences stock price target on herpes drug progress | 1 | Investing.com | ||
| 13:58 | Abbott's Lisa Earnhardt to deliver DeviceTalks Minnesota keynote | 4 | MassDevice | ||
| 13:58 | Fortschritte bei Herpes-Medikament: Guggenheim hebt Kursziel für Assembly Biosciences an | 4 | Investing.com Deutsch | ||
| 13:54 | Mizuho raises Corbus Pharmaceuticals stock price target on CRB-701 | 1 | Investing.com | ||
| 13:46 | Mizuho erhöht Kursziel für Corbus Pharmaceuticals auf 40 US-Dollar | 1 | Investing.com Deutsch | ||
| 13:38 | NOVO NORDISK A/S - Stabilität als strategische Basis | 4 | Maximilian Berger | ||
| 13:36 | Medicus Pharma Ltd: Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention | 1 | GlobeNewswire (USA) | ||
| 13:36 | PMGC Holdings Inc.: NorthStrive Defense Tech Acquires Multi-Domain Drone Payload Technology Option for Defense and Commercial Applications | 1 | GlobeNewswire (USA) | ||
| 13:34 | How Will Skyrizi and Rinvoq Shape AbbVie's Q1 Immunology Sales? | 3 | Zacks | ||
| 13:30 | HERON THERAPEUTICS, INC. /DE/ - 8-K, Current Report | - | SEC Filings | ||
| 13:24 | AbbVie lowers Q1 and FY 2026 earnings outlook following $744M R&D charge | 3 | Seeking Alpha | ||
| 13:22 | Opus Genetics sichert sich Finanzierung von bis zu 155 Mio. US-Dollar von Oberland Capital | 3 | Investing.com Deutsch | ||
| 13:18 | Opus Genetics secures up to $155M financing from Oberland Capital | 6 | Investing.com | ||
| 13:18 | EXCLUSIVE: Medicus Pharma Refines Trial Design To Cut Costs, Accelerate Development For Enlarged Prostate Patients | 2 | Benzinga.com | ||
| 13:06 | Opus Genetics, Inc.: Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital | 178 | GlobeNewswire (Europe) | - Agreement includes up to $155 million in non-dilutive funding with an upfront payment of $35 million and a $5 million equity investment -- Strategic financing to accelerate development of earlier-stage... ► Artikel lesen | |
| 13:06 | NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx's Preservative-Free Ketamine Application | 174 | GlobeNewswire (Europe) | NRx has received a letter from the FDA Office of Generic Drugs indicating preliminary alignment on labeling for NRx's preservative-free ketamine product. Labeling remains subject to final supervisory... ► Artikel lesen | |
| 13:00 | Innocan Pharma Corporation: Innocan Pharma Announces Closing of Additional Debenture | 167 | PR Newswire | The Debenture will bear interest at the rate of 10% per annum and matures at the earlier of: (i) 12 months from the date of issuance; and (ii) the completion of the Company's previously announced proposed... ► Artikel lesen | |
| 12:54 | Vertical Aerospace achieves major milestone with eVTOL flight development | 3 | Seeking Alpha | ||
| 12:42 | Vertical Aerospace completes piloted eVTOL transition flight | 1 | Investing.com | ||
| 12:34 | Vertical Aerospace gelingt Meilenstein bei bemanntem eVTOL-Testflug | 2 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
 | NOVO NORDISK | 4 | 40 | -0,09 % | Novo Nordisk-Aktie: 27 € in Aussicht | Das Dilemma rund um Novo Nordisk bleibt allgegenwärtig. Die Themen sind dabei äußerst vielseitig, wie erst in der vorangegangenen Woche die Redaktion hier per Beitrag rund um eine neue Medikamentenzulassung... ► Artikel lesen | |
| VERTICAL AEROSPACE | 4 | - | -0,51 % | Vertical Aerospace Achieves Historic Piloted Thrustborne Transition | Industry first under strict oversight of the UK Civil Aviation Authority (CAA), which is working in close collaboration with the European Union Aviation Safety Agency (EASA) toward certification... ► Artikel lesen | ||
| BAYER | 3 | 36 | 0,00 % | Bayer-Aktie: Wochen der Entscheidung stehen an | Vor der Bayer-Aktie liegen einige wichtige Wochen, in denen sich viel für den Konzern entscheiden dürfte. Das sagen die Experten und das müssen Anleger jetzt wissen. Die Aktie von Bayer hat sich zuletzt... ► Artikel lesen | ||
| OPUS GENETICS | 3 | 2 | -1,78 % | Opus Genetics, Inc.: Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital | - Agreement includes up to $155 million in non-dilutive funding with an upfront payment of $35 million and a $5 million equity investment -- Strategic financing to accelerate development of earlier-stage... ► Artikel lesen | ||
| ABBVIE | 2 | 55 | -0,33 % | AbbVie verbucht F&E-Aufwendungen von 744 Mio. US-Dollar für Q1 und passt Prognose für 2026 an | |||
| MEDICUS PHARMA | 2 | 12 | 0,00 % | Medicus Pharma Ltd: Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate | PHILADELPHIA, March 30, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | ||
| INNOCAN PHARMA | 2 | 2 | +1,46 % | Innocan Pharma Corporation: Innocan Pharma Announces Closing of Additional Debenture | The Debenture will bear interest at the rate of 10% per annum and matures at the earlier of: (i) 12 months from the date of issuance; and (ii) the completion of the Company's previously announced proposed... ► Artikel lesen | ||
| CORBUS PHARMACEUTICALS | 2 | 1 | -1,69 % | Mizuho raises Corbus Pharmaceuticals stock price target on CRB-701 | |||
| AVALO THERAPEUTICS | 2 | - | -2,87 % | Citizens initiates Avalo Therapeutics stock with outperform rating | |||
| ELI LILLY | 1 | 125 | -0,05 % | Cyber-Security im Check | Eli Lilly: KI-Clou, Rio Tinto: Aluminium-Preise & Rheinmetall | Cyber-Security im Check | Eli Lilly: KI-Clou, Rio Tinto: Aluminium-Preise & Rheinmetal ► Artikel lesen |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| SCHOTT PHARMA AG & CO KGAA | 13,700 | 18,70 | +36 % | 3 | 11 | - | |||
| DOCMORRIS AG | 5,430 | 7,37 | +36 % | 5 | 9 | 4 | |||
| MERCK KGAA | 109,80 | 141,60 | +29 % | 12 | 8 | - | |||
| ELI LILLY AND COMPANY | 811,00 | 968,78 | +19 % | 1 | - | - | |||
| NOVO NORDISK A/S | 31,930 | 37,47 | +17 % | 16 | 31 | 3 | ||
| SANOFI SA | 82,53 | 94,57 | +15 % | 11 | 18 | - | |||
| ASTRAZENECA PLC | 175,55 | 191,96 | +9 % | 26 | 1 | 7 | |||
| BAYER AG | 39,695 | 41,71 | +5 % | 27 | 11 | 1 | |||
| PFIZER INC | 24,510 | 23,93 | -2 % | 1 | 5 | - | |||
| NOVARTIS AG | 133,58 | 129,80 | -3 % | 6 | 14 | 4 | |||
| GSK PLC | 24,550 | 22,79 | -7 % | 5 | 11 | 16 | |||
| DERMAPHARM HOLDING SE | 47,250 | 34 | -28 % | - | 2 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.